Substance
ID:1194
Names and Identifiers
IUPAC name
(3R,5R,6S,7S,8R,11R,12S,13R,14S,15S)-14-{[(2S,3R,4S,6R)-3-(acetyloxy)-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-12-{[(2R,4S,5S,6S)-5-(acetyloxy)-4-methoxy-6-methyloxan-2-yl]oxy}-5,7,8,11,13,15-hexamethyl-4,10-dioxo-1,9-dioxaspiro[2.13]hexadecan-6-yl acetate
IUPAC Traditional name
troleandomycin
Brand Name
EvramicinaTaoMatromicinaCyclamycinTreolmicinaTribiocillina
Synonyms
Oleandomycin triacetyl esterTroleandomycinTriacetyloleandomycinOleandocetineOleandomycin, triacetate (ester)Oleandomycin triacetate
Properties
No Data Available
Click here to submit data
Molecule Details
Drug Groups
approved
Description
A macrolide antibiotic that is similar to erythromycin.
Indication
For the treatment of Pneumococcal pneumonia due to susceptible strains and group A beta-hemolytic streptococcal infections of the upper respiratory tract.
Pharmacology
Troleandomycin is a macrolide antibiotic that is similar to erythromycin. It is active in vitro against the following gram-positive organisms: Streptococcus pyogenes and Diplococcus pneumoniae.
Toxicity
Symptoms of overdose include diarrhea, nausea, stomach cramps, and vomiting.
Affected Organisms
Enteric bacteria and other eubacteria
External Links
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data